Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

INVESTIGATION OF RETINITIS PIGMENTOSA

Identifieur interne : 002570 ( Main/Curation ); précédent : 002569; suivant : 002571

INVESTIGATION OF RETINITIS PIGMENTOSA

Auteurs : A. C. Bird [Royaume-Uni]

Source :

RBID : ISTEX:CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225

Abstract

Retinitis pigmentosa is a solitary manifestation o1 separate genetically determined disorders in which there is progressive loss of vision and the appearance of characteristic fundus abnormalities. It is likely that each disease contained within this family of disorders has a different aetiology, a consideration which is important to the clinician, the researcher and the therapist. To the clinician it is essential to be able to identify the inheritance of the disorder in order to give educated genetic advice. It is the responsibility of the clinician to sub‐divide retinitis pigmentosa into purer samples of disease since without such a sub‐division research is unlikely to be fruitful. It is unreasonable to expect a biochemist to define systemic biochemical abnormalities if blood is analysed from a series of patients, each of which has a different disorder. If the cause of retinal degeneration in an animal homologue of human retinitis pigmentosa is identified the question is then raised as to whether the abnormality is relevant to human disease and, if so, to which one. Moreover, if a metabolic abnormality is identified in one disease it will not necessarily be found in others and similarly, if therapy is effective in one form of the disease it may not be effective for all patients. A sub‐division of retinitis pigmentosa may be made on the basis of inheritance of the disorder, on the basis of morphologic changes in the fundus, and on the qualitative functional changes identified. Such observations may also give some clues as to the pathogenesis of the different forms of RP or at least indicate in which cell system the primary disorders lie and will also show in what way the defect interferes with cell function. In this paper it is hoped to show that studies undertaken by the various disciplines within ophthalmology have now made limited achievements towards the goals of subdividing retinitis pigmentosa (RP) into purer samples of disease and typifying the functional and morphological attributes of the constituent disorders.

Url:
DOI: 10.1111/j.1442-9071.1982.tb00367.x

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">INVESTIGATION OF RETINITIS PIGMENTOSA</title>
<author>
<name sortKey="Bird, A C" sort="Bird, A C" uniqKey="Bird A" first="A. C." last="Bird">A. C. Bird</name>
<affiliation wicri:level="3">
<mods:affiliation>London</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225</idno>
<date when="1982" year="1982">1982</date>
<idno type="doi">10.1111/j.1442-9071.1982.tb00367.x</idno>
<idno type="url">https://api.istex.fr/document/CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002920</idno>
<idno type="wicri:Area/Main/Curation">002570</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">INVESTIGATION OF RETINITIS PIGMENTOSA</title>
<author>
<name sortKey="Bird, A C" sort="Bird, A C" uniqKey="Bird A" first="A. C." last="Bird">A. C. Bird</name>
<affiliation wicri:level="3">
<mods:affiliation>London</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Australian Journal of Opthalmology</title>
<idno type="ISSN">0310-1177</idno>
<idno type="eISSN">1442-9071</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1982-05">1982-05</date>
<biblScope unit="volume">10</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="99">99</biblScope>
<biblScope unit="page" to="106">106</biblScope>
</imprint>
<idno type="ISSN">0310-1177</idno>
</series>
<idno type="istex">CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225</idno>
<idno type="DOI">10.1111/j.1442-9071.1982.tb00367.x</idno>
<idno type="ArticleID">CEO99</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0310-1177</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Retinitis pigmentosa is a solitary manifestation o1 separate genetically determined disorders in which there is progressive loss of vision and the appearance of characteristic fundus abnormalities. It is likely that each disease contained within this family of disorders has a different aetiology, a consideration which is important to the clinician, the researcher and the therapist. To the clinician it is essential to be able to identify the inheritance of the disorder in order to give educated genetic advice. It is the responsibility of the clinician to sub‐divide retinitis pigmentosa into purer samples of disease since without such a sub‐division research is unlikely to be fruitful. It is unreasonable to expect a biochemist to define systemic biochemical abnormalities if blood is analysed from a series of patients, each of which has a different disorder. If the cause of retinal degeneration in an animal homologue of human retinitis pigmentosa is identified the question is then raised as to whether the abnormality is relevant to human disease and, if so, to which one. Moreover, if a metabolic abnormality is identified in one disease it will not necessarily be found in others and similarly, if therapy is effective in one form of the disease it may not be effective for all patients. A sub‐division of retinitis pigmentosa may be made on the basis of inheritance of the disorder, on the basis of morphologic changes in the fundus, and on the qualitative functional changes identified. Such observations may also give some clues as to the pathogenesis of the different forms of RP or at least indicate in which cell system the primary disorders lie and will also show in what way the defect interferes with cell function. In this paper it is hoped to show that studies undertaken by the various disciplines within ophthalmology have now made limited achievements towards the goals of subdividing retinitis pigmentosa (RP) into purer samples of disease and typifying the functional and morphological attributes of the constituent disorders.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002570 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002570 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:CC9BB3C25CCC3401D2E7250DCECC666C2D1CB225
   |texte=   INVESTIGATION OF RETINITIS PIGMENTOSA
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024